Rodrigo P. Lira-Cavalcanti
Campinas, RS, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Reply to Comment on: Long-term Results of Trimethoprim Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis.
Journal: American journal of ophthalmology
Published: August 03, 2020
Macular and choroidal thickness after intracameral moxifloxacin for prevention of postcataract endophthalmitis.
Journal: Journal of cataract and refractive surgery
Published: May 20, 2020
Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis.
Journal: American journal of ophthalmology
Published: September 22, 2018
Safety and efficacy of intracameral moxifloxacin for prevention of post-cataract endophthalmitis: Randomized controlled clinical trial.
Journal: Journal of cataract and refractive surgery
Published: August 27, 2018
Long-term safety of intracameral moxifloxacin after cataract surgery.
Journal: Journal of cataract and refractive surgery
Published: October 01, 2016
Trimethoprim-Sulfamethoxazole Versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A Three-Year Follow-up.
Journal: American journal of ophthalmology
Published: March 17, 2016
Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 25, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026